Featured Research

from universities, journals, and other organizations

Synthetic, dissolving plates ease repairs of nasal septum defects

Date:
January 19, 2010
Source:
JAMA and Archives Journals
Summary:
Attaching cartilage to plates made of the resorbable material polydioxanone appears to facilitate corrective surgery on the nasal septum, the thin cartilage separating the two airways, according to a new report.

Attaching cartilage to plates made of the resorbable material polydioxanone appears to facilitate corrective surgery on the nasal septum, the thin cartilage separating the two airways, according to a report in the January/February issue of Archives of Facial Plastic Surgery, one of the JAMA/Archives journals.

Conventional septoplasty, or surgery to straighten a deviated septum, is not always possible because the surgical manipulations involved weaken the septal cartilage, according to background information in the article. "For decades, the inner nose remained untouched in nasal septal surgery because of these problems, and plastic surgeons attempted to correct only the nasal septum regions visible from the outside," the authors write. "Only in the past 40 years have surgical innovations allowed correction of cosmetic and functional deformities in a single session."

However, these procedures are sometimes ineffective in complex cases; it is difficult to strengthen the cartilage enough to support the structure of the nose without compromising cosmetic or functional concerns. To resolve these issues, Miriam Boenisch, M.D., Ph.D., then of District Hospital Steyr, Steyr, Austria, and now of Medicent Linz, Linz, Austria, and Gilbert J. Nolst Trenitι, M.D., Ph.D., of the Academic Medical Center of the University of Amsterdam, report on the use of resorbable polydioxanone plates during septoplasty. Cartilage is removed from the septum and sutured to a polydioxanone plate cut to the same size. This combined graft is then re-implanted.

The procedure was performed on 396 patients beginning in 1996. Results were evaluated by patient report, photographs and measurements of nasal function at follow-up examinations periodically after surgery (patients were followed for an average of 12 months and a maximum of 10 years). No immediate complications such as bleeding, inflammatory reactions or tissue death occurred, nor were there long-term complications such as perforation or thickening of the septum or rejection of the implant.

A straight nasal septum was achieved in 369 patients (93.2 percent), and the same number reported improvement of the nasal airway. Two months after surgery, nasal function testing showed improved nasal flow in 324 patients (81.8 percent).

Eighteen patients (4.5 percent) required revision surgery to correct redeviation or other slight deformities. In eight (2 percent), the septum was displaced again but did not cause functional problems or the patients did not want revision surgery.

"Surgical correction of a deviated nasal septum is one of the most frequently performed surgical procedures," the authors write. Of an average of 1.2 cases per 1,000 North American and European individuals, about 90 percent of the surgical procedures are routine. The other 10 percent require complex correction. "The use of resorbable polydioxanone plate facilitates this surgical technique."

"To date, we have encountered no short- or long-term complications as a consequence of the use of polydioxanone plate," they conclude. "The use of polydioxanone plate during septal surgery facilitates external septoplasty, corrects several combined nasal deformities such as post-traumatic and iatrogenic [medically induced] irregularities and avoids postoperative saddle nose deformity, without risk to the patient."


Story Source:

The above story is based on materials provided by JAMA and Archives Journals. Note: Materials may be edited for content and length.


Journal Reference:

  1. Miriam Boenisch; Gilbert J. Nolst Trenite. Reconstruction of the Nasal Septum Using Polydioxanone Plate. Arch Facial Plast Surg, 2010; 12 (1): 4-10 [link]

Cite This Page:

JAMA and Archives Journals. "Synthetic, dissolving plates ease repairs of nasal septum defects." ScienceDaily. ScienceDaily, 19 January 2010. <www.sciencedaily.com/releases/2010/01/100118161941.htm>.
JAMA and Archives Journals. (2010, January 19). Synthetic, dissolving plates ease repairs of nasal septum defects. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2010/01/100118161941.htm
JAMA and Archives Journals. "Synthetic, dissolving plates ease repairs of nasal septum defects." ScienceDaily. www.sciencedaily.com/releases/2010/01/100118161941.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins